SY
Syros Pharmaceuticals, Inc.
SYRS · OTC
$0.00 +0.00% (+$0.00)
1M +300.00%
Market Cap $9.39K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
0 /100
Declining Rev. growth 13.01%
Book val. growth 43.12%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 77.33%
Net margin 1,656.34%
Op. margin 1,298.19%
Quality
1 /100
Poor ROIC 91.82%
ROA 97.86%
Asset turnover 0.06x
Debt
50 /100
Moderate Debt/Equity 3.73x
Current ratio 3.95x
Int. coverage -31.10x
Stability
42 /100
Moderate Beta 1.36x
Rev. volatility 52.31%
EPS volatility 13.07%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o SYRS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James E. Bradner
Employees
68
Headquarters
Cambridge
Nadchodzące wydarzenia
29 PAŹ
Earnings
Upcoming earnings report